levofloxacin has been researched along with Gram-Positive Bacterial Infections in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (10.77) | 18.2507 |
2000's | 28 (43.08) | 29.6817 |
2010's | 28 (43.08) | 24.3611 |
2020's | 2 (3.08) | 2.80 |
Authors | Studies |
---|---|
Black, JA; Hanson, ND; Hong, SG; Hossain, A; Moland, ES; Thomson, KS; Wickman, PA | 1 |
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
Cohen, MA; Ellsworth, E; Gage, JW; Gibson, GW; Gracheck, SJ; Hanna, DL; Huband, MD; Skerlos, LA; Stier, MA; Sulavik, MC; Zurack, M | 1 |
Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
Benton, BM; Draghi, DC; Krause, KM; Pillar, C; Sahm, DF; Thornsberry, C | 1 |
Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
Aung, TT; Beuerman, RW; Cao, D; Koh, JJ; Lakshminarayanan, R; Li, J; Lim, F; Lin, S; Liu, S; Ren, L; Tan, DT; Verma, C; Wang, L; Wang, Y; Zou, H | 1 |
Fan, X; Kang, X; Luo, S; Luo, X; Wang, G; Wei, Y; Zhao, S | 1 |
Ahmad, A; Albert, A; Bird, B; Maheshwari, P; Patel, D | 1 |
Balzaretti, M; Grosini, A; Piacentini, V; Poddighe, D; Pulcrano, G | 1 |
Gotoh, N; Hayashi, N; Ikeda, F; Ishii, R; Kanayama, S; Matsumoto, T; Okamoto, K | 1 |
Fukushima, H; Hara, H; Harada, T; Hyo, Y | 1 |
Jones, BM; Keedy, C; Wynn, M | 1 |
Aroca-Ferri, M; Bolaños-Rivero, M; Pérez-Arellano, JL; Suárez-Hormiga, L | 1 |
Ahmed, S; Aitken, SL; Ariza-Heredia, E; Doan, VP; Gulbis, AM; Yeh, JC | 1 |
Baj, A; Beltramini, GA; Giannì, AB; Laganà, FC | 1 |
Kawasaki, S; Mitani, A; Mito, T; Ohashi, Y; Suzuki, T; Tasaka, Y; Uda, T | 1 |
Baddour, LM; Kaufmann, BA; Kurz, M; Widmer, AF | 1 |
Cantón, R; Espinal, P; Garcia-Alonso, F; Gargallo-Viola, D; López, Y; Tato, M; Vila, J | 1 |
Chen, DS; Hsu, HY; Sand, D; Schur, M; She, R; Shulman, IA | 1 |
Darouiche, RO; Steenbergen, J; Umeh, O; Wagenlehner, FM; Yuan, G | 1 |
Chan, JF; Yuen, KY | 1 |
Edwards, JK | 1 |
Alonso, JM; Cantón, R; Cuartero, C; Del Campo, R; López, J; Lozano, S; Rodríguez, JD; Rodríguez-Domínguez, M; Ruiz-Garbajosa, P; Sánchez-Díaz, AM; Tedim, AP | 1 |
Berghofen, A; Krämer, BK; Krüger, B; Mircheva, M; Popa, C | 1 |
Boyles, T | 1 |
Kielstein, JT; Schmidt, JJ | 1 |
Darouiche, RO; Umeh, O; Wagenlehner, FM | 1 |
Chang, SJ; Hsieh, CH; Yang, SS | 1 |
Kobayakawa, S; Tochikubo, T; Tsuchiya, Y; Tsuji, A | 1 |
Crapis, M; Cristini, F; Furlanut, M; Negri, C; Pavan, F; Pea, F; Scudeller, L; Viale, P; Zamparini, E; Zuiani, C | 1 |
Eames, T; Grabein, B; Kroth, J; Wollenberg, A | 1 |
Cheong, HJ; Choi, WS; Jo, YM; Kim, HS; Kim, JY; Kim, MJ; Kim, WJ; Park, DW; Sohn, JW; Song, JY; Youn, YK | 1 |
Bartoletti, R; Boddi, V; Cai, T; Malossini, G; Mazzoli, S; Meacci, F; Mondaini, N | 1 |
Arakawa, S; Fujisawa, M; Kawabata, M; Matsumoto, M; Nakano, Y; Shigemura, K; Shirakawa, T; Tanaka, K; Yasufuku, T | 1 |
Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA | 1 |
Lemus-Peñaloza, J; Parra-Riffo, H | 1 |
Kawasaki, S; Mito, T; Ohashi, Y; Suzuki, T; Tasaka, Y; Uda, T; Uno, T | 1 |
Matoba, AY | 1 |
Dijstelbloem, Y; Huijgens, PC; Simoons-Smit, AM; Timmers, GJ; Touw, DJ; van Winkelhoff, AJ; Vandenbroucke-Grauls, CM | 1 |
Akins, RL; Davis, WR; Gopalachar, A; Siddiqui, AA | 1 |
Chan, AC; Chan, EC; Lai, KT; Ma, ES; Wong, CL; Yam, WC | 1 |
Anon, J; Kahn, J; Khashab, M; Paglia, M; Poole, M; Xiang, J | 1 |
Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M | 1 |
Gómez Gómez, J; López Fornás, F; Lorente Salinas, I; Martínez García, F; Pérez Salmerón, J; Roldán Conesa, D; Ruiz Gómez, J; Segovia Hernández, M; Valdés Chávarri, M | 1 |
Drago, L; Esposito, S; Leone, S; Marchetti, F; Marvaso, A; Noviello, S | 1 |
Craig, M; Cumpston, AD; Devetten, MP; Ericson, SG; Hobbs, GR; Sarwari, AR | 1 |
Esposito, S; Ianniello, F; Leone, S; Noviello, S | 1 |
Barry, AL; Fuchs, PC; Pfaller, MA | 1 |
Chow, AT; Fish, DN | 1 |
Alperstein, P; France, K; Isenberg, HD | 1 |
Peters, G; von Eiff, C | 1 |
Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M | 1 |
Bjarnason, J; Blondeau, JM; Laskowski, R; Stewart, C | 1 |
Bell, T; Benenson, R; Kellogg, J; Manzella, J; Pellerin, G; Pope, D; Robertson, M | 1 |
Crawford, S; Jorgensen, JH; McElmeel, ML; Murray, CK; Walter, EA | 1 |
Budanov, SV; Smirnova, LB | 1 |
Ho, PL; Ng, TK; Que, TL; Tse, CW; Yip, EK; Yuen, KY; Yung, RW | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
5 review(s) available for levofloxacin and Gram-Positive Bacterial Infections
Article | Year |
---|---|
First report of Kocuria marina bloodstream infection unrelated to a central venous catheter: a mini-review on an emerging and under-recognized opportunistic pathogen.
Topics: Anti-Bacterial Agents; Asthma; Bacteremia; Body Mass Index; Central Venous Catheters; Female; Gram-Positive Bacterial Infections; Humans; Leg Ulcer; Levofloxacin; Micrococcaceae; Middle Aged; Risk Factors; Smoking; Treatment Outcome | 2017 |
Severe levofloxacin-induced hypoglycaemia: a case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Catheter-Related Infections; Drug Therapy, Combination; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Hypoglycemia; Immunocompromised Host; Kidney Failure, Chronic; Levofloxacin; Male; Ofloxacin; Renal Dialysis; Sepsis; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciprofloxacin; Decision Making; Drug Resistance; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Leukemia; Levofloxacin; Lymphoma; Neoplasms; Neutropenia; Ofloxacin | 2006 |
The clinical pharmacokinetics of levofloxacin.
Topics: Anti-Infective Agents; Clinical Trials, Phase III as Topic; Drug Interactions; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Ofloxacin | 1997 |
[Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].
Topics: Anti-Infective Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Ofloxacin | 2001 |
10 trial(s) available for levofloxacin and Gram-Positive Bacterial Infections
Article | Year |
---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation.
Topics: Aged; Allografts; Cefpodoxime; Ceftizoxime; Clostridiales; Disease-Free Survival; Drug Resistance, Multiple, Bacterial; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Survival Rate; Unrelated Donors | 2019 |
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2015 |
The Effectiveness of Prophylactic Antibiotics with Oral Levofloxacin against Post-Shock Wave Lithotripsy Infectious Complications: A Randomized Controlled Trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Incidence; Levofloxacin; Lithotripsy; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Digestive System; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Pharynx; Staphylococcus aureus | 2004 |
A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Sinusitis; Treatment Outcome | 2006 |
A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Placebos; Pyuria; Single-Blind Method; Treatment Outcome; Urinary Catheterization; Urinary Tract Infections | 2006 |
The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Neutropenia; Ofloxacin; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous | 2007 |
Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Middle Aged; Ofloxacin; Treatment Outcome | 1999 |
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins | 1999 |
50 other study(ies) available for levofloxacin and Gram-Positive Bacterial Infections
Article | Year |
---|---|
In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci.
Topics: Drug Resistance, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Microbial Sensitivity Tests; Quinolones | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Pyrrolidines; Quinazolinones; Topoisomerase II Inhibitors | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Prospective Studies; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; United States | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |
Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity.
Topics: Animals; Anti-Bacterial Agents; Cornea; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Staphylococcal Infections; Surface-Active Agents; Xanthones | 2017 |
Analysis of virulence genes, drug resistance detection, and pathogenicity in Enterococcus from farm animals.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cattle; Cefotaxime; Chickens; Ciprofloxacin; Dogs; Drug Resistance; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Levofloxacin; Mice; Microbial Sensitivity Tests; Sulfamethoxazole; Swine; Vancomycin; Virulence; Virulence Factors | 2022 |
Bacillus pumilus-Borne Food Poisoning in an Immunosuppressed Host.
Topics: Anti-Bacterial Agents; Bacillus pumilus; Ceftriaxone; Doxycycline; Foodborne Diseases; Gastroenteritis; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunosuppression Therapy; Kidney Transplantation; Levofloxacin; Male; Middle Aged; MTOR Inhibitors; Pancreas Transplantation | 2021 |
Bactericidal activity and post-antibiotic effect of ozenoxacin against Propionibacterium acnes.
Topics: Aminopyridines; Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Propionibacterium acnes; Quinolones | 2017 |
Nasal septal abscess caused by anaerobic bacteria of oral flora.
Topics: Abscess; Accidental Falls; Aged; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Nasal Septum; Paracentesis; Peptostreptococcus; Tomography, X-Ray Computed; Tooth Socket; Veillonella | 2019 |
Successful treatment of Enterococcus faecalis bacteremia with dalbavancin as an outpatient in an intravenous drug user.
Topics: Adult; Bacteremia; Blood Culture; Catheterization, Central Venous; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Outpatients; Substance Abuse, Intravenous; Teicoplanin | 2018 |
[Intra-fascial abscess by Bacillus cereus].
Topics: Abscess; Anti-Bacterial Agents; Athletic Injuries; Bacillus cereus; Fever; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Young Adult | 2019 |
Maxillary sinusitis after sinus lift due to Gemella morbillorum: antibiotic and surgical treatment.
Topics: Anti-Bacterial Agents; Bone Transplantation; Drug Hypersensitivity; Endoscopy; Female; Follow-Up Studies; Gemella; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Maxillary Sinusitis; Middle Aged; Penicillins; Reoperation; Rifampin; Sinus Floor Augmentation; Surgical Wound Infection; Vancomycin | 2013 |
Ocular penetration and efficacy of levofloxacin using different drug-delivery techniques for the prevention of endophthalmitis in rabbit eyes with posterior capsule rupture.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Drug Delivery Systems; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Levofloxacin; Moxifloxacin; Ophthalmic Solutions; Posterior Capsular Rupture, Ocular; Rabbits; Vitreous Body | 2014 |
Propionibacterium acnes prosthetic valve endocarditis with abscess formation: a case report.
Topics: Abscess; Adult; Anti-Bacterial Agents; Ceftriaxone; Communicable Diseases; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Levofloxacin; Male; Middle Aged; Propionibacterium acnes; Prosthesis-Related Infections; Rifampin; Treatment Outcome | 2014 |
In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.
Topics: Aminopyridines; Anti-Bacterial Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Quinolones; Selection, Genetic; Sequence Analysis, DNA | 2015 |
Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, County; Humans; Levofloxacin; Los Angeles; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2015 |
A new ASPECT for complicated urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Infection: Ceftolozane-tazobactam gives a new ASPECT to the fight against antimicrobial resistance.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; beta-Lactam Resistance; Blood; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Molecular Typing; Neutropenia; Prospective Studies; Real-Time Polymerase Chain Reaction; Risk Assessment | 2016 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection - Authors' reply.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Preventive effect against post-cataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Colony Count, Microbial; Drug Delivery Systems; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Lens Implantation, Intraocular; Lenses, Intraocular; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Postoperative Complications; Rabbits | 2008 |
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Discitis; Drug Monitoring; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Rifampin; Treatment Outcome; Young Adult | 2009 |
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cephalosporins; Cetuximab; Ciprofloxacin; ErbB Receptors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Paronychia; Retrospective Studies; Skin | 2010 |
Liver abscess and empyema due to Lactococcus lactis cremoris.
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Drainage; Empyema; Gram-Positive Bacterial Infections; Humans; Lactococcus lactis; Levofloxacin; Liver Abscess; Male; Microbial Sensitivity Tests; Ofloxacin; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2010 |
Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Prostatitis; Young Adult | 2011 |
Mechanisms of and risk factors for fluoroquinolone resistance in clinical Enterococcus faecalis isolates from patients with urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Ofloxacin; Risk Factors; Urinary Tract Infections; Young Adult | 2011 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2012 |
Moxifloxacin as postoperative prophylaxis for Enterococcus faecalis-induced endophthalmitis after cataract surgery in aphakic rabbits.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Aphakia, Postcataract; Aza Compounds; Disease Models, Animal; Electroretinography; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacterial Infections; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Phacoemulsification; Quinolines; Rabbits; Time Factors | 2013 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Urinary tract infection caused by Aerococcus viridans, a case report.
Topics: Aged; Aged, 80 and over; Bacteremia; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Ofloxacin; Streptococcaceae; Urinary Tract Infections | 2004 |
Kocuria kristinae infection associated with acute cholecystitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cholecystitis; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Micrococcaceae; Middle Aged; Ofloxacin | 2005 |
[Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
Topics: Aged; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Teicoplanin; Virginiamycin | 2006 |
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dioxolanes; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Staphylococcus aureus; Urinary Tract Infections | 2006 |
Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests.
Topics: Evaluation Studies as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1993 |
In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Corynebacterium; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1998 |
In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Micrococcus; Neutropenia; Ofloxacin | 1998 |
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 1999 |
Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms.
Topics: Anti-Infective Agents; Aza Compounds; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines | 2000 |
Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Enterococcus; Erythromycin; Female; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Risk Factors; Vancomycin Resistance | 2000 |
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Microbial; Fever; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Ofloxacin; Streptococcaceae | 2001 |
Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Hong Kong; Humans; Levofloxacin; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin Resistance | 2001 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |